Skip to main content

Peer Review reports

From: Discovery of novel 2,3,4,5-tetrahydrospiro[benzo[c]azepine-1,1’-cyclohexan]-5-ol derivatives as PARP-1 inhibitors

Original Submission
13 Apr 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
3 May 2023 Author responded Author comments - Shuai Li
Resubmission - Version 3
3 May 2023 Submitted Manuscript version 3
4 May 2023 Author responded Author comments - Shuai Li
Resubmission - Version 4
4 May 2023 Submitted Manuscript version 4
5 May 2023 Author responded Author comments - Shuai Li
Resubmission - Version 5
5 May 2023 Submitted Manuscript version 5
9 Jun 2023 Reviewed Reviewer Report
11 Sep 2023 Reviewed Reviewer Report
2 Oct 2023 Author responded Author comments - Shuai Li
Resubmission - Version 6
2 Oct 2023 Submitted Manuscript version 6
14 Oct 2023 Reviewed Reviewer Report
16 Oct 2023 Reviewed Reviewer Report
17 Oct 2023 Author responded Author comments - Shuai Li
Resubmission - Version 7
17 Oct 2023 Submitted Manuscript version 7
17 Oct 2023 Author responded Author comments - Shuai Li
Resubmission - Version 8
17 Oct 2023 Submitted Manuscript version 8
Publishing
17 Oct 2023 Editorially accepted
27 Oct 2023 Article published 10.1186/s13065-023-01060-8

You can find further information about peer review here.

Back to article page